NantHealth has announced the acquisition of The OpenNMS Group, an open-source network management company, which will operate as a subsidiary of NantHealth.

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

InSphero has announced InFloat™: a unique shipping system designed to keep plates of assay-ready 3D InSight™ microtissues upright, secure, and at physiological temperatures suitable for live cell cultures during domestic and international transit.

Wiley has announced the debut of KnowItAll 2020, featuring a new streamlined interface and tools to accelerate the spectral analysis of unknown compounds, plus new tools specifically designed for drug classification using infrared analysis.

The company has extended program benefits to oncology laboratories and fast-tracking access to comprehensive molecular profiling on the Genexus System.

AMSBIO is offering a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.

LabVantage has announced that a Fortune 100 global consumer packaged goods (CPG) company has deployed the LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.

Researchers have used the Linkam THMS600 temperature-controlled stage to explore phase transitions in mixed liquid systems and laser-induced nucleation.

As further step into the green future, My Green Lab has certified several Eppendorf ULT freezers (-80°C) to ACT, the Environmental Impact Factor label.

The ImmunoCAP Specific IgE alpha-Gal Allergen Component test has been cleared by the FDA for in vitro diagnostic use, aiding specialists and other healthcare providers as they diagnose a patient’s sensitization to the alpha-Gal carbohydrate found in mammalian (red) meat and assess their risk for an anaphylactic reaction.